Explore the latest deal across all financial deal types and actionable insights by Theme and Sector to support your business activities and workflows.

Europe: Five largest Equity Offering deals by value in the Pharmaceuticals sector (LTM June 2022)

  • A total of 127 Equity Offering deals (pending and completed) were announced in the Pharmaceuticals of the Europe region, in the last twelve months resulting in a total deal value of over $7,090.2 million. In the LTM period, March 2022 turned out to be the most prolific in terms of deal size, with a total deal value of $1,118.4 million, resulting in an average deal value of $58.9 million during that month. On the other hand, the month of March 2022 was the most prolific in terms of deal volume, recording a total of 19 deals, resulting in an average deal value of $58.9 million during that month.

  • Of the 127 deals, the deal secured between Baker Bros Advisors LP; Bpifrance Participations SA; Braidwell; Fairmount Partners LP; RA Capital Management LP; Venrock Healthcare Capital Partners LP; Vivo Capital LLC and DBV Technologies SA, was the largest Equity Offering deal in the Europe Pharmaceuticals sector, which was valued at $193.8 million and was completed on June 9, 2022. The second-largest deal was between The Goldman Sachs Group Inc and Mithra Pharmaceuticals SA, while the third-largest deal was between Novo Holdings AS and Oxford BioMedica Plc. The The Goldman Sachs Group Inc-Mithra Pharmaceuticals SA deal and the Novo Holdings AS-Oxford BioMedica Plc deal were valued at $114.5 million and $107.3 million, respectively. The fourth-largest deal was between Abiomed Inc; Alger Associates, Inc.; Kennedy Lewis Investment Management LLC; Simos Kedikoglou; Squarepoint Capital LLP-Impulse Dynamics NV valued at $101.0 million, whereas the deal between Pfizer Inc-Valneva SE valued at $95.0 million was the fifth-largest deal.

  • Cumulatively, the top five deals amounted to $611.6 million and accounted for nearly 8.63% of the total deals (by value) announced during the last twelve months. The Europe region accounted for 10.81% of the total Equity Offering deals done globally, and accounted for 0.57% of the total deal size on a global scale.

Europe: Five largest Equity Offering deals by value in the Pharmaceuticals sector (LTM June 2022)

Published: June 2022
Source: GlobalData

Explore the latest deal across all financial deal types and actionable insights by Theme and Sector to support your business activities and workflows. Explore the latest deal across all financial deal types and actionable insights by Theme and Sector to support your business activities and workflows. Visit Report Store
Still looking?

Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward